The board and shareholders of Hovione have named Dr Jean-Luc Herbeaux (right) as CEO from 1 April. He had originally joined the firm as COO in May 2020, after multiple leadership positions at Evonik, where he last headed the Health Care business line.
CDMO Hovione used CPhI Worldwide 2021 in Milan to announce plans to invest $170 million over the years 2020-2022 to expand both capacities and capabilities at three sites in Portugal, Ireland, and New Jersey. About 300 jobs will be created as a result. These reflect its increasing focus on spray drying, high potency and particle engineering.